相关实验视频
Updated: Jul 4, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.4K
病例报告:早期分子确认和聚二硫酸管理系统性伪类型I类型的伪类型
Einas H Alkhatib1, Deirdre Bartlett2, Roopa Kanakatti Shankar1,3
1Department of Endocrinology, Children's National Hospital, Washington, D.C., United States.
Frontiers in endocrinology
|January 30, 2024
概括
在婴儿中,系统性1型假型荷尔多斯特症 (PHA) 可能具有挑战性. 这一案例证明了使用硫酸聚二烯和补充剂的成功管理,改善了电解质平衡和患者的结果.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 遗传学 是一个遗传学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 第1型假型荷尔多斯特症 (PHA) 具有阿尔多斯特耐药性的特征,在新生儿中具有严重的风险.
- 系统性PHA类型1是一种自体递归形式,通常比类型更严重的电解质失衡.
- 早期诊断和分子确认对于管理这种罕见的疾病至关重要.
研究的目的:
- 描述一种新的治疗方法,用于婴儿的全身PHA1型.
- 为了突出聚二醇硫酸盐在管理严重的电解质干扰方面的成功使用.
- 介绍一个分子确诊的全身PHA1型患者的长期结果.
主要方法:
- 分子遗传测试证实PHA类型1与SCNN1A.中的同卵性致病性框架转移变体.
- 治疗包括通过管给食的聚二烯硫酸盐,以及化补充剂.
- 患者逐渐转换为直接给药的聚二硫酸盐.
主要成果:
- 婴儿出现了严重的低血症,高血症和代谢性酸症.
- 通过聚二硫酸盐和补充剂成功控制电解质失衡.
- 患者保持了稳定的电解质和良好的健康状况,即使在间歇性疾病期间.
结论:
- 聚二烯硫酸盐,战略性地管理,可以是一个有效的治疗系统性PHA类型1在婴儿.
- 这种方法有助于更好地控制电解质,改善患者管理,降低死亡风险.
- 对PHA类型1的分子确认对于指导适当的治疗策略至关重要.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
560
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
560
Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
Antihypertensive Drugs: Direct Renin Inhibitors
630
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
630
Renal Tubule and Collecting Duct
986
The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
986
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Adrenal Gland Disorders
1.5K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.5K

